Skip to main content
SpringerLink
Log in

Prognostic factors and evaluation of surgical management of hepatic metastases from colorectal origin: A 10-year single-institute experience

  • Original Articles
  • Published:
Journal of Gastrointestinal Surgery

Abstract

The aim of this study was to determine prognostic factors and outcome after liver resection for colorectal metastases in 102 patients over a period of 10 years. A stepwise procedure using proportional hazard regression analysis was used to identify prognostic factors. Estimated survival at 2 years was 71%, and at 5 years, 29% (Kaplan-Meier). Of 19 patients with isolated liver recurrence, 6 had a second metastasectomy; 4 of the 6 are still alive.Wefound that the number of hepatic lesions on computed tomography (P = 0.012), the interval between resection of the primary colon tumor and the hepatic metastasectomy (P = 0.012), and synchronicity of the primary and the hepatic metastasis (P = 0.048) showed evidence of independent prognostic value regarding survival. Resection of hepatic colorectal metastases may result in long-term survival. Patients with recurrence after a first liver resection may benefit from a repeat metastasectomy. Our data suggest there is no strong predictor of survival. Survival seems to decrease with increasing number of metastases found on computed tomography.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Nederlandse Kankerbestrijding/KoninginWilhelmina Fonds, jaarverslag 1998.

  2. Kavolius J, Fong Y, Blumgart LH. Surgical resection of metastatic liver tumors. Surg Oncol Clin North Am 1996;5:337–352.

    CAS  Google Scholar 

  3. Jaffe BM, Donegan WL, Watson F, Spratt JS Jr. Factors in.uencing survival in patients with untreated hepatic metastases. Surg Gynecol Obstet 1968;127:1–11.

    PubMed  CAS  Google Scholar 

  4. Bengmark S, Hafstrom L. The natural history of primary and secondary malignant tumors of the liver. I. The prognosis for patients with hepatic metastases from colonic and rectal carcinoma by laparotomy. Cancer 1969;23:198–202.

    Article  PubMed  CAS  Google Scholar 

  5. Chang AE, Schneider PD, Sugarbaker PH, Simpson C, Culnane M, Steinberg SM. A prospective randomised trial of regional vs. systemic continuous 5-FU chemotherapy in the treatment of colorectal metastases. Ann Surg 1987;206:685–693.

    Article  PubMed  CAS  Google Scholar 

  6. Cunningham D, Pyrhonen S, James RD, et al. Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer. Lancet 1998;352:1413–1418.

    Article  PubMed  CAS  Google Scholar 

  7. Hughes KS, Simon R, Songhorabodi S, et al. Resection of the liver for colorectal carcinoma metastases:A multi-institutional study of patterns of recurrence. Surgery 1986;100:278–284.

    PubMed  CAS  Google Scholar 

  8. Scheele J, Stang R, Altendorf-Hofmann A, Paul M. Resection of colorectal liver metastases. World J Surg 1995;19:59–71.

    Article  PubMed  CAS  Google Scholar 

  9. Scheele J, Stangl R, Altendorf-Hofmann A. Hepatic metastases from colorectal carcinoma: Impact of surgical resection on the natural history. Br J Surg 1990;77:1241–1246.

    Article  PubMed  CAS  Google Scholar 

  10. Cox DR. Regression models and life-tables. J R Stat Soc 1972;B34:187–220.

    Google Scholar 

  11. Therneau TM, Grambsch PM, Flemming TR. Martingalebased residuals for survival models. Biometrika 1990;77:147–160.

    Article  Google Scholar 

  12. Schoenfeld D. Partial residuals for the proportional hazards regression model. Biometrika 1982;69:239–241.

    Article  Google Scholar 

  13. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457–481.

    Article  Google Scholar 

  14. Peto R, Pike MC, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II: Analysis and examples. Br J Cancer 1977; 35:1–39.

    PubMed  CAS  Google Scholar 

  15. Wright P. Adjusted P-values for simultaneous inference. Biometrics 1992;48:1005–1013.

    Article  Google Scholar 

  16. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: Analysis of 1001 consecutive cases. Ann Surg 1999;230:309–318.

    Article  PubMed  CAS  Google Scholar 

  17. Hughes K, Scheele J, Sugarbaker PH. Surgery for colorectal cancer metastatic to the liver. Optimizing the results of treatment. Surg Clin North Am 1989;69:339–359.

    PubMed  CAS  Google Scholar 

  18. Nordlinger B, Guiguet M, Vaillant JC, et al. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Cancer 1996;77:1254–1262.

    Article  PubMed  CAS  Google Scholar 

  19. Harms J, Obst T, Thorban S, et al. The role of surgery in the treatment of liver metastases for colorectal cancer patients. Hepatogastroenterology 1999;46:2321–2328.

    PubMed  CAS  Google Scholar 

  20. Ballantyne GH, Quin J. Surgical treatment of liver metastases in patients with colorectal cancer. Cancer 1993;71:4252–4266.

    Article  PubMed  CAS  Google Scholar 

  21. Kaneko M, Eguchi K, Ohmatsu H, et al. Peripheral lung cancer: Screening and detection with low-dose spiral CT versus radiography. Radiology 1996;201:798–802.

    PubMed  CAS  Google Scholar 

  22. Maublant J, Vuillez JP, Talbot JN, et al. Positron emission tomography (PET) and (F-18)-.uorodeoxyglucose (FDG) in cancerology. Bull Cancer 1998;85:935–950.

    PubMed  CAS  Google Scholar 

  23. Elias D, Cavalcanti A, Sabourin JC, et al. Resection of liver metastases from colorectal cancer: The real impact of the surgical margin. Eur J Surg Oncol 1998;24:174–179.

    Article  PubMed  CAS  Google Scholar 

  24. Doci R, Gennari L, Bignami P, Montalto F, Morabito A, Bozzetti F. One hundred patients with hepatic metastasis from colorectal cancer treated by resection: Analysis of prognostic determinants. Br J Surg 1991;78:797–801.

    Article  PubMed  CAS  Google Scholar 

  25. Sitzmann JV, Greene PS. Perioperative predictors of morbidity following hepatic resection of neoplasm. A multivariate analysis of a single surgeon experience with 105 patients. Ann Surg 1994;219:13–17.

    Article  PubMed  CAS  Google Scholar 

  26. Melendez J, Ferri E, Zwillman M, et al. Extended hepatic resection: A 6-year retrospective study of risk factors for perioperative mortality. J Am Coll Surg 2001;192:47–53.

    Article  PubMed  CAS  Google Scholar 

  27. Bolton JS, Fuhrman GM. Survival after resection of multiple bilobar hepatic metastases from colorectal carcinoma. Ann Surg 2000;231:743–751.

    Article  PubMed  CAS  Google Scholar 

  28. Asbun HJ, Hughes KS. Management of recurrent and metastatic colorectal carcinoma. Surg Clin North Am 1993;73:145–166.

    PubMed  CAS  Google Scholar 

  29. Vogt P, Raab R, Ringe B, Pichlmayr R. Resection of synchronous liver metastases from colorectal cancer. World J Surg 1991;15:62–67.

    Article  PubMed  CAS  Google Scholar 

  30. Sugarbaker P. Repeat hepatectomy for colorectal metastases. J Hepatobiliary Pancreatic Surg 1999;6:30–38.

    Article  CAS  Google Scholar 

  31. Bismuth H, Adam R, Navarro F, Castaing D, Engerran L, Abascal A. Re-resection for colorectal liver metastasis. Surg Oncol Clin North Am 1996;5:353–364.

    CAS  Google Scholar 

  32. Yamamoto J, Kosuge T, Shimada K, Yamasaki S, Moriya Y, Sugihara K. Repeat liver resection for recurrent colorectal liver metastases. Am J Surg 1999;178:275–281.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Surgery, TheNetherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066, CX Amsterdam, Netherlands

    Eduard L. A. R. Mutsaerts M.D., Ph.D., Serge van Ruth M.D., Ph.D., Emiel J. T. Rutgers M.D., Ph.D., F.R.C.S. & Frits van Coevorden M.D., Ph.D.

  2. Radiotherapy, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands

    Augustinus A. M. Hart Ph.D.

Authors
  1. Eduard L. A. R. Mutsaerts M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Serge van Ruth M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Frans A. N. Zoetmulder M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Emiel J. T. Rutgers M.D., Ph.D., F.R.C.S.
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Augustinus A. M. Hart Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Frits van Coevorden M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mutsaerts, E.L.A.R., van Ruth, S., Zoetmulder, F.A.N. et al. Prognostic factors and evaluation of surgical management of hepatic metastases from colorectal origin: A 10-year single-institute experience. J Gastrointest Surg 9, 178–186 (2005). https://doi.org/10.1016/j.gassur.2004.06.005

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1016/j.gassur.2004.06.005

Key Words

Search

Navigation